PT2385 [Ligand Id: 12707] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL4173075
  • endothelial PAS domain protein 1/Endothelial PAS domain-containing protein 1 in Human [ChEMBL: CHEMBL1744522] [GtoPdb: 3148] [UniProtKB: Q99814]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
endothelial PAS domain protein 1/Endothelial PAS domain-containing protein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1744522] [GtoPdb: 3148] [UniProtKB: Q99814]
GtoPdb Binding affinity for the PAS-B domain of hHIF1α determined by ITC - 7.3 pKd 50 nM Kd Cancer Res (2016) 76: 5491-500 [PMID:27635045]
ChEMBL Binding affinity to His-tagged HIF-2alpha PAS-B domain (unknown origin) after 2 hrs by scintillation proximity assay B 7.92 pIC50 12 nM IC50 J Med Chem (2018) 61: 9691-9721 [PMID:30289716]
ChEMBL Inhibition of N-(3-Chlorophenyl-4,6-t2)-4-nitrobenzo[c][1,2,5]oxadiazol-5-amine binding to his-tagged HIF-2alpha PAS-B domain (unknown origin) measured after 1 hr by scintillation proximity assay B 7.92 pIC50 12 nM IC50 J Med Chem (2019) 62: 6876-6893 [PMID:31282155]
ChEMBL Antagonist activity at HIF-2alpha in human 786-O cells assessed as free plasma adjusted EC50 for reduction in VEGFA concentration after 24 hrs by ELISA B 6.8 pEC50 158 nM EC50 J Med Chem (2018) 61: 9691-9721 [PMID:30289716]
ChEMBL Inhibition of HIF-2alpha (unknown origin) expressed in human 786-O cells assessed as reduction in VEGFA level incubated for 20 hrs prior to compound compound washout followed by supplementation of growth medium and subsequent compound addition and measured after 24 hrs by ELISA B 7.34 pEC50 46 nM EC50 J Med Chem (2019) 62: 6876-6893 [PMID:31282155]
ChEMBL Antagonist activity at HIF-2alpha in human 786-O cells assessed as reduction in VEGFA concentration after 24 hrs by ELISA B 7.39 pEC50 41 nM EC50 J Med Chem (2018) 61: 9691-9721 [PMID:30289716]
ChEMBL Antagonist activity at HIF-2alpha in human 786-O cells co-expressing HIF responsive element after 24 hrs by ONE-Glo luciferase reporter gene assay B 7.57 pEC50 27 nM EC50 J Med Chem (2018) 61: 9691-9721 [PMID:30289716]
ChEMBL Inhibition of HIF-2alpha (unknown origin) expressed in human 786-O cells measured after 24 hrs by one-glo luciferase reporter gene assay B 7.57 pEC50 27 nM EC50 J Med Chem (2019) 62: 6876-6893 [PMID:31282155]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]